Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Vejle – page 11

184 clinical trials in Vejle, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Vejle at a glance
184
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

184 trials in Vejle

Open in trial search

Radius fracture

Not recruiting

Study on Brachial Plexus Nerve Block with Epinephrine and Lidocaine for Adults with Distal Radius Fracture Needing Closed Reduction

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Epinephrine
  • Sponsor:Rigshospitalet

Breast cancer

Not recruiting

Study on Atorvastatin for Patients with Early Breast Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Region Midtjylland

Alpha-1 antitrypsin deficiency+1

Not recruiting

Study on Long-Term Safety of INBRX-101 for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human ALPHA-1-PROTEINASE inhibitor immunoglobulin G fusion protein, recombinant
  • Sponsor:Sanofi AATD Inc.

Colorectal cancer metastatic

Not recruiting

Study on Tocotrienol and Bevacizumab for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Lillebaelt Hospital

Colon cancer

Not recruiting

Study on the Effects of Capecitabine and Oxaliplatin in Patients with Locally Advanced Colon Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Lillebaelt Hospital

Haematological malignancy+1

Not recruiting

Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Genmab A/S

B-cell lymphoma refractory

Not recruiting

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Genmab A/S

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Genmab A/S

Asthma

Not recruiting

Study on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
  • Sponsor:AstraZeneca AB

HER2 positive breast cancer

Not recruiting

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Osteoarthritis

Not recruiting

Study on the Safety of Allocetra for Patients with Knee Osteoarthritis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
  • Sponsor:Enlivex Therapeutics Ltd.

Breast cancer

Not recruiting

Study on Alpelisib with Fulvestrant or Letrozole for Patients with Advanced Breast Cancer and PIK3CA Mutation After Previous Treatments

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Vejle

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on advanced treatments for various cancer types, particularly metastatic prostate cancer, chronic lymphocytic leukemia, and colorectal cancer. Studies are evaluating innovative therapies and treatment combinations.

  • Metastatic Castration-Resistant Prostate Cancer Studies
  • Chronic Lymphocytic Leukemia Treatments
  • Multiple Myeloma Management

Research emphasizes personalized treatment approaches and novel drug combinations to improve patient outcomes.

02 Inflammatory Conditions

Investigations into treatments for chronic inflammatory conditions, including rhinosinusitis, psoriatic arthritis, and inflammatory bowel diseases. Studies are evaluating biologic therapies and their optimal usage.

  • Nasal Polyps Treatment
  • Psoriatic Arthritis Management
  • IBD Therapeutic Monitoring

Focus on developing targeted therapies and understanding treatment duration optimization.

03 Respiratory Medicine

Research into respiratory conditions, particularly focusing on severe asthma and viral lung infections. Studies are examining new therapeutic approaches and treatment effectiveness.

  • Uncontrolled Asthma Interventions
  • Viral Lung Infection Management
  • Pulmonary Sarcoidosis Treatment

Emphasis on developing innovative treatments for patients with difficult-to-control respiratory conditions.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.